Subscribe To
Precede Biosciences Announces First Scientific Data from its Liquid Biopsy Platform to be Presented as an Oral Presentation at ESMO 2023
Data from more than 400 patients across 15 cancers demonstrate the significance of the Precede approach to informing therapeutic decision making and clinical diagnoses BOSTON, Oct. 15, 2023 (GLOBE NEWSWIRE) — Precede Biosciences, a company impacting the development and use of precision medicines with a first-in-class liquid biopsy platform, advances its mission with a first […] The post Precede Biosciences Announces First Scientific Data from its Liquid Biopsy Platform to be Presented as an Oral...
Read More
Content Topics
Precede
Biosciences
Announces
First
Scientific
Data
From
Liquid
Biopsy
Platform
Presented
Presentation
Forex
Posted: Oct 15 2023, 22:05
Author Name: forextv
Views: 102027